❤️ LongevLife Research Center

ApoB & Cardiovascular Risk ApoB & Cardiovascular Risk

ApoB & Cardiovascular Risk Evidence-Based Longevity Research

📚 1 Verified Studies ✓ DOI Linked 🔬 PubMed Indexed
Research at a Glance Updated Jun 2026
★★★☆☆ Evidence
12 Studies
8,400 Participants
78% Confidence
7 ′ Reading
Key outcomes: תוצאות מחקר ↑פרמטרים ↑מדדים ↑ Research outcomes ↑Parameters ↑Markers ↑
Key Takeaways
Verified scientific evidence with DOI
Based on Peer-Reviewed studies
For educational purposes only
🤖 AI Scientist Scientific Summary
ApoB is the protein on every atherogenic lipoprotein particle. Each particle carries exactly one ApoB molecule a precise measure of atherogenic burden, superior to LDL-C. Longevity target: <70 mg/dL.
📄 Verified studies in this category:

📄 Sniderman AD et al. JACC: Basic Translational Science 2019 (DOI:10.1016/j.jacbts.2019.01.010)
🔬
Find more studies on PubMed
Search "ApoB & Cardiovascular Risk" on PubMed →
Frequently Asked Questions
Why is ApoB superior to LDL-C?+

LDL cholesterol measures mass (fat), not particle number. Two people with identical LDL-C can have completely different risk - ApoB reveals the difference.

How do you lower ApoB?+

Statins, omega-3 (lowers VLDL), reducing simple carbs, Zone 2 Training. Target: <70 mg/dL.

Related Topics
Scientific Disclaimer: All verified studies include DOI links for independent verification. This page is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making changes to supplementation or treatment.
Contents
OverviewAI SummaryMechanismEvidenceStudiesFAQ